Please ensure Javascript is enabled for purposes of website accessibility

Will These 3 Early Stock Winners of 2014 Keep Up Their Good Fortunes?

By Dan Carroll - Feb 24, 2014 at 2:30PM

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Will Intuitive Surgical, NuVasive, and Globus Medical continue their early good fortune for investors throughout the rest of the year?

The market has had a rocky first two months of 2014 after last year's astronomical boom, but a few medical device stocks have shaken off the dust to roar to great gains on the year so far. Intuitive Surgical (ISRG -0.49%) is perhaps the most surprising stock to soar up the charts in 2014: Intuitive's stock crashed in 2013 over fears of slowing growth and the cost of the company's da Vinci robotic surgery machines, but shares of the innovative health care company have taken off by more than 13% year to date.

Intuitive is not alone. Globus Medical (GMED 0.94%), a spinal implant manufacturer, has taken off for investors in the early going of 2014. The same holds true for NuVasive (NUVA 0.76%), one of med tech's brightest stars last year that hasn't lost any of its luster as of late.

But can these surging med tech stocks keep impressing investors as 2014 rolls along? Don't leave it up to guesswork: Find out in the video below, as Motley Fool contributor Dan Carroll tells you all you need to know about what's driven these three surprising stocks higher so far this year -- and whether or not they're in danger of slipping up in the coming months.

Dan Carroll has no position in any stocks mentioned. The Motley Fool recommends Intuitive Surgical. The Motley Fool owns shares of Intuitive Surgical. Try any of our Foolish newsletter services free for 30 days. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.

Invest Smarter with The Motley Fool

Join Over 1 Million Premium Members Receiving…

  • New Stock Picks Each Month
  • Detailed Analysis of Companies
  • Model Portfolios
  • Live Streaming During Market Hours
  • And Much More
Get Started Now

Stocks Mentioned

Intuitive Surgical, Inc. Stock Quote
Intuitive Surgical, Inc.
ISRG
$239.13 (-0.49%) $-1.19
NuVasive, Inc. Stock Quote
NuVasive, Inc.
NUVA
$51.86 (0.76%) $0.39
Globus Medical, Inc. Stock Quote
Globus Medical, Inc.
GMED
$63.52 (0.94%) $0.59

*Average returns of all recommendations since inception. Cost basis and return based on previous market day close.

Related Articles

Motley Fool Returns

Motley Fool Stock Advisor

Market-beating stocks from our award-winning analyst team.

Stock Advisor Returns
377%
 
S&P 500 Returns
123%

Calculated by average return of all stock recommendations since inception of the Stock Advisor service in February of 2002. Returns as of 08/08/2022.

Discounted offers are only available to new members. Stock Advisor list price is $199 per year.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.